Babies, Blemishes and FDA: A History of Accutane Regulation in the United States

DSpace/Manakin Repository

Babies, Blemishes and FDA: A History of Accutane Regulation in the United States

Citable link to this page

. . . . . .

Title: Babies, Blemishes and FDA: A History of Accutane Regulation in the United States
Author: Green, Julia
Citation: Babies, Blemishes and FDA: A History of Accutane Regulation in the United States (2002 Third Year Paper)
Full Text & Related Files:
Abstract: This paper takes a journalistic approach, tracing the chronology of Accutane in the U.S. in order to fill in the gaps of the story that has inspired so much controversy. Accutane has repeatedly pushed the frontier of FDA regulation, as the agency struggled to adapt its tools to meet the challenge of an extremely effective and extremely dangerous medication. By emphasizing the evolving American response to the high level of risk associated with Accutane, I hope to provide the material needed to evaluate the strengths and weaknesses of our current regulatory framework.
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:8963867

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters